Besides opnMe, Koester established scientific crowdsourcing as a new open innovation tool to attract externally generated new therapeutic concepts for Boehringer Ingelheim’s pre-clinical pipeline.
Boehringer Ingelheim Innovation Unit head Paola Casarosa said: “Zongertinib’s efficacy and tolerability profile has the ...
Boehringer Ingelheim's support aligns perfectly with our vision to create a healthy India for all. It enables us to empower the startup community, fostering an ecosystem of innovation and ...